| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 14.989 | 34.517 | 40.448 | 52.775 | 55.410 |
| Total Income - EUR | - | - | - | - | - | 14.989 | 34.517 | 40.448 | 52.775 | 55.410 |
| Total Expenses - EUR | - | - | - | - | - | 5.472 | 11.910 | 18.508 | 18.206 | 21.464 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 9.517 | 22.608 | 21.940 | 34.570 | 33.946 |
| Net Profit/Loss - EUR | - | - | - | - | - | 9.375 | 22.304 | 21.582 | 34.146 | 32.317 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuroassess S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 6.535 | 3.811 | 2.636 | 1.314 | 1.593 |
| Current Assets | - | - | - | - | - | 6.533 | 28.338 | 21.927 | 36.675 | 60.629 |
| Inventories | - | - | - | - | - | 76 | 1.524 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 303 | 10.832 | 4.208 | 110 | 29.532 |
| Cash | - | - | - | - | - | 6.154 | 15.982 | 17.719 | 36.564 | 31.097 |
| Shareholders Funds | - | - | - | - | - | 9.417 | 31.512 | 21.630 | 35.494 | 32.365 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 3.651 | 636 | 2.932 | 2.495 | 29.857 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuroassess S.r.l.